The demand for ketoprofen in the Chinese market has increased exponentially, mainly because of the demographic and epidemiological changes due to an aging population and increased incidence of chronic pain disorders. Greater health care investments and innovations have sustained this heightened demand for substitutes of pain relief medications, especially non-steroidal anti-inflammatory drugs (NSAIDs). Consequently, ketoprofen is increasingly common in forms such as tablets, gels, and injectables. At the production level, producers have enjoyed enhanced efficiencies and encountered stabilizing feedstock prices, while others have encountered inventory management challenges after recent price drops. The prevailing environment indicates the potential for recovery, with projections of sustained expansion in the months to come. Furthermore, the freight market is also stable, with logistics providers adjusting in order to make deliveries in good time as demand for imports rises. Overall, the prospects for ketoprofen in China are good on the back of sound demand fundamentals and enhanced market conditions.
